Skip to content
HowShorted

TENET HEALTHCARE CORP short interest in 2025

In 2025, TENET HEALTHCARE CORP's disclosed short interest ran from 3.73% of shares outstanding on 15 Jan 2025 to 2.99% on 31 Dec 2025, a change of -0.74 percentage points. The year's high was 4.45% on 13 Jun 2025 and its low 1.92% on 15 Apr 2025, averaging 3.08% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.58 days on 31 Dec 2025. Full history: TENET HEALTHCARE CORP.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for TENET HEALTHCARE CORP in 2025

2025 in figures

Start of year
3.73% (15 Jan 2025)
End of year
2.99% (31 Dec 2025)
Change
-0.74 pp
High
4.45% (13 Jun 2025)
Low
1.92% (15 Apr 2025)
Average
3.08%
Highest days to cover
3.58 (31 Dec 2025)
SEC filings marked
8

Every report in 2025

TENET HEALTHCARE CORP short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 20253.73%3.35
31 Jan 20253.12%2.98
14 Feb 20253.60%2.01results (8-K)
28 Feb 20253.61%1.7610-K filed
14 Mar 20254.07%2.55
31 Mar 20252.56%1.36
15 Apr 20251.92%1.10
30 Apr 20252.18%1.1610-Q filed, results (8-K)
15 May 20252.56%1.57
30 May 20253.02%2.09
13 Jun 20254.45%2.31
30 Jun 20253.77%1.71
15 Jul 20253.14%2.85
31 Jul 20253.50%1.37results (8-K), 10-Q filed
15 Aug 20252.70%2.75
29 Aug 20252.65%2.34
15 Sep 20252.85%1.98
30 Sep 20252.79%2.08
15 Oct 20252.88%2.86
31 Oct 20252.98%2.2010-Q filed, results (8-K)
14 Nov 20252.59%2.56
28 Nov 20253.31%2.32
15 Dec 20253.05%3.04
31 Dec 20252.99%3.58

See also: TENET HEALTHCARE CORP's full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.